Universe Pharmaceuticals Inc (UPC) — Cash Flow Quality Index

Latest as of June 2022: 3.53x

Universe Pharmaceuticals Inc (UPC) has a Cash Flow Quality Index of 3.53x as of June 2022. Operating cash flow of $6.12 Million exceeds net income of $1.73 Million, indicating high earnings quality where cash backs reported profits. Explore Universe Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.

Cash Flow Quality Index

3.53x
Operating CF / Net Income

Operating Cash Flow

$6.12 Million
USD

Net Income

$1.73 Million
USD

Data as of

Jun 2022
Most recent filing

Universe Pharmaceuticals Inc Cash Flow Quality Index (2018–2021)

Historical Cash Flow Quality Index for Universe Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Universe Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Universe Pharmaceuticals Inc (2018–2021)

Year-by-year earnings quality comparison for Universe Pharmaceuticals Inc. For live market cap and the full company financial profile, see UPC market cap.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -0.18x $-2.06 Million $11.32 Million ▼ -122.4%
2020 0.81x $6.12 Million $7.56 Million ▼ -53.7%
2019 1.75x $13.20 Million $7.55 Million ▲ +198.4%
2018 0.59x $4.46 Million $7.60 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.